Abstract Hypermanganesemia is commonly recognized in human patients with hepatic insufficiency and portosystemic shunting. Since manganese is neurotoxic, increases in brain manganese concentrations have been implicated in the development of hepatic encephalopathy although a direct causative role has yet to be demonstrated. Evaluate manganese concentrations in dogs with a naturally occurring congenital shunt before and after attenuation as well as longitudinally following the changes in hepatic encephalopathy grade. Our study demonstrated that attenuation of the shunt resolved encephalopathy, significantly reduced postprandial bile acids, yet a hypermanganasemic state persisted. This study demonstrates that resolution of hepatic encephalopathy can occur without the correction of hypermanganesemia, indicating that increased manganese concentrations alone do not play a causative role in encephalopathy. Our study further demonstrates the value of the canine congenital portosystemic shunt as a naturally occurring spontaneous model of human hepatic encephalopathy.
Introduction
Hepatic encephalopathy (HE) is a common neuropsychiatric syndrome which occurs in patients with liver disease. The pathogenesis of HE is multifactorial with ammonia and inflammation currently considered to be the main causes of neurological disturbances in patients with liver disease. However, other metabolic disturbances, notably in sodium homeostasis, have been linked to the development of HE (McPhail et al. 2010; Mas 2006) .
Human patients with liver disease frequently develop hypermanganesemia (Spahr et al. 1996) . Dietary manganese (Mn) is efficiently absorbed through the gastrointestinal tract, then extracted by hepatocytes (Schramm and Brandt 1986) . Absorbed Mn is then excreted in bile against a high concentration gradient (Klaassen 1974 ). This process is extremely efficient and only approximately 2 % of absorbed Mn ultimately reaches the systemic circulation (Davis et al. 1993 ). In the situation of reduced hepatic function and portosystemic shunting, high concentrations of Mn are delivered into the systemic circulation (Mizoguchi et al. 2001; Uchino et al. 2007 ). As Mn is neurotoxic, hypermanganesemia has been linked to the development of HE (Layrargues et al. 1998) .
The pathogenesis of Mn neurotoxicity appears to be multifactorial. Astrocytes accumulate high Mn concentrations, causing release of reactive oxygen species, an increase in peripheral type benzodiazepine receptors and also neurosteroid production (Aschner et al. 1992 ). Manganese has also been shown to potentiate microglial release of inflammatory mediators in response to LPS and also increase ammonia concentrations in the CNS (Butterworth 2008; Jayakumar et al. 2004; Rivera-Mancia et al. 2012; Filipov et al. 2005) .
Despite the established association between liver disease and hypermanganesemia, the precise role of Mn in the development of HE remains unclear. Aside from a case report demonstrating a reduction in globus pallidus hyperintensity, a finding which is pathognomic for Mn deposition, after occlusion of a portosystemic shunt and treatment for hepatic encephalopathy, there is only one study in humans which measured whole blood manganese before and after an improvement in hepatic function (Taguchi et al. 1999; Lazeyras et al. 2002; Barron et al. 1994 ). This study examined Mn concentrations before and after orthotopic liver transplantation (OLT) which failed to demonstrate a significant reduction in Mn concentrations 4 months after transplant. Furthermore, Mn concentrations remained increased in 6 of 12 patients that had increased pre-operative concentrations. In addition, Mn concentrations became increased in a further 3 that had normal concentrations pre-operatively. Potential explanations for this finding include the persistence of portal-systemic collaterals, recurrence of hepatitis or concurrent disease contributing to high Mn concentrations. However, interpretation of this data is difficult due to the presence of a wide range of comorbidities in the patient cohort. Consequently, there is a clear need to clarify whether the reducing portosystemic shunting reduces Mn concentrations.
A common congenital abnormality in dogs is a portosystemic shunt (cPSS) which commonly causes spontaneous HE. We have demonstrated that the pathophysiology of HE in dogs with liver disease is very similar to human HE, with ammonia and inflammation playing a key role in the development of neurological abnormalities in dogs with a cPSS (Tivers et al. 2014; Shawcross et al. 2004 Shawcross et al. , 2007 Gow et al. 2012) . Crucially, we have also demonstrated that dogs with a cPSS frequently have an increase in Mn concentrations (Gow et al. 2010) . Consequently, dogs with a cPSS are a highly informative, spontaneous model of human HE in which the pathogenesis of neurological complications associated with liver disorders can be explored without the need for the inducing liver disease in otherwise healthy animals.
In dogs with a cPSS, the abnormal vessel can be surgically attenuated with subsequent resolution of HE in the majority of cases (Hunt and Hughes 1999) . This offers an excellent natural experimental system, free from many of the confounding variables which are invariably present in human studies, in which to examine whether the manganese concentrations normalise following surgical attenuation of a portosystemic shunt (Lazeyras et al. 2002) . As hepatic blood flow improves after surgery, and hepatic volume increases rapidly, it would be expected that this would allow efficient hepatic first pass extraction of portal blood Mn and systemic concentrations would reduce after shunt ligation (Kummeling et al. 2010) . The objective of this study was to test the hypothesis that cPSS attenuation would resolve HE, and hypermanganesemia in dogs with a cPSS.
Materials and methods
Dogs with a diagnosis of a cPSS (shunt confirmed by direct visualization at surgery), which could be occluded or attenuated were enrolled into the study. Whole blood EDTA samples were collected before and after shunt attenuation. A bile acid stimulation test, which is a well established and widely used assay to assess for the presence of portosystemic shunting in dogs, was also performed at the same time points (Center et al. 1991) . At time of sampling, the grade of HE (i.e., graded 0-4) was recorded based on a previously described system (Rothuizen 2009 ). The whole blood EDTA samples were frozen at -70 o C before being transported on dry ice as a batch to the Scottish Trace Element and Micronutrient Reference Laboratory. Manganese concentrations were determined in whole blood by graphite furnace atomic absorption spectrometry after dilution with Triton X-100 solution. The interassay coefficient of variation was 5.4 %. Bile acid measurement was performed on an ILab 650 using a colorimetric, 2 point kinetic fixed time enzymatic reaction by Dialab. Whole blood Mn results from 14 previously reported dogs were used to define a range for healthy dogs (250-1052 μmol/L) (Gow et al. 2010) .
A Wilcoxon matched-pairs test was used to compare HE scores, whole blood Mn and bile acids before and after surgical ligation. The same test was used to compare whole blood Mn concentrations before and after in the dogs that underwent complete ligation As some dogs would retain flow through their shunt after surgery, analysis was also performed in those dogs which had a post-prandial bile acids below 40 μmol/L after surgery. Statistical analysis was performed with GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego California USA) and P of <0.05 was considered significant. The study was approved by the University of Edinburgh Veterinary Ethics Committee.
Results
Whole blood Mn concentrations were measured before and after surgery in 26 dogs with a cPSS (2 males neutered, 7 intact males, 14 intact females, 3 females neutered, age range 17 weeks to 5 years 11 months, median 15 months). All dogs were diagnosed with an extra-hepatic shunting vessel. Eight dogs underwent full ligation with suture at surgery with the remaining 18 undergoing partial attenuation by suture then cellophane banding under one procedure. The median time between first sampling and surgery was 28 days (range 0-49 days) and between surgery and second sampling was 28 days (range 28-56 days).
Post-prandial bile acid concentrations were significantly lower post-operatively than prior to surgery (median presurgery 218 μmol/L, range 37-490 μmol/L, median postsurgery 39 μmol/L, range 9-98 μmol/L, p=0.0006). Ten dogs had grade 1 and two dogs had grade 2 hepatic encephalopathy with 14 asymptomatic prior to surgery. No dog exhibited signs of HE at the time of post attenuation sampling. Hepatic encephalopathy scores were significantly lower at the time of post-operative sampling compared to the preoperative time point (p=0.0012). There was no significant difference between the pre and post-surgery whole blood Mn measurements (Fig. 1 , median pre-surgery 2969 nmol/L, range 687-14,494 nmol/L, median postsurgery 2296 nmol/L, range 404-6608 nmol/L, p=0.12). Examining only those 8 dogs which underwent complete ligation, there was no significant difference between the pre and post-surgery whole blood Mn measurements (median pre-surgery 2996 nmol/L, range 1427-14,494 nmol/L, median post-surgery 3188 nmol/ L, range 1501-5891 nmol/L, p=1.0). Blood manganese concentrations increased in 8 dogs after shunt attenuation. Three of these dogs had complete ligation performed. Ten dogs had a post-prandial bile acids of below 40 μmol/L after surgery. There was no significant difference in these dogs between the pre and postsurgery whole blood Mn measurements (median presurgery 3153 nmol/L, range 1427-14,494 nmol/L, median post-surgery 2163 nmol/L, range 683-4690 nmol/L, p=0.08). This was still markedly above the value of the healthy dogs.
Discussion
The central finding of this study was that clinical signs of HE resolved and bile acid concentrations significantly decreased following shunt attenuation yet, whole blood manganese concentrations did not decrease significantly. Indeed, in eight individuals blood Mn concentrations increased. This finding is consistent with the OLT study where blood Mn concentrations remained increased after liver transplantation (Lazeyras et al. 2002) .
The reason(s) why blood Mn concentrations remain high in dogs post cPSS attenuation is unclear. Dogs with a cPSS have reduced hepatic volume and post-operatively, despite improved portal delivery of Mn to the liver, a lack of functional hepatocytes may initially prevent efficient extraction of Mn (Stieger et al. 2007 ). Hepatic volume has been shown to increase rapidly post-operatively with the greatest increase between days 0 to 8 post attenuation, thus it would be expected that efficiency of portal Mn extraction would likewise increase (Kummeling et al. 2010) . As Mn distribution is reasonably uniform through most body tissues, cPSS cases would have tissue Mn to equilibrate with whole blood concentrations, also slowing post-operative resolution of hypermanganesaemia (Dobson et al. 2004 ). Although Mn is actively transported into the CNS, efflux appears to be by diffusion (Yokel 2009 ). As a result, the half-life of Mn in the CNS may be increased compared to other tissues. If brain Mn was contributing significantly to the syndrome of HE then the slow reduction in CNS Mn would be expected to cause persistence of the signs after surgery. It has also been demonstrated that systemic Mn is less Fig. 1 Whole blood manganese concentrations of 26 dogs with a congenital portosystemic shunt before (Pre), and after (Post) surgical shunt ligation. Range of healthy control population is shown as the shaded area. There was no significant difference in concentrations before and after ligation (p=0.12) efficiently extracted by the liver than portally delivered Mn (Teeguarden et al. 2007 ). This may be due to difference in oxidation state; the majority of portally delivered Manganese is Mn 2+ however during systemic circulation this can be oxidised by ceruloplasmin to Mn 3+ and bound to transferrin (Teeguarden et al. 2007) .
Although there was resolution of clinical signs and a significant improvement in post-prandial bile acids postoperatively, there may have been residual shunting allowing continued delivery of Mn directly into the systemic circulation. Postoperative imaging to quantify continued flow through the shunt or recruitment of additional collateral vessels was not clinically justified but would have been useful to assess if this was a factor in sustaining systemic hypermanganesemia.
Longer-term monitoring of whole blood Mn in cases of cPSS which have undergone surgical attenuation would be useful to assess if concentrations gradually decrease. Persistent hypermanganesemia after clinically successful surgery may have significant clinical consequences with continued CNS Mn deposition causing subtle long term neurological abnormalities that current canine HE scoring systems cannot detect. Long term follow up of neurological status and ultimately examination of CNS Mn concentration and histopathological examination would be insightful.
In summary, this study demonstrated that dogs with a congenital portosystemic shunt are an instructive natural model in which Mn homeostasis can be probed, free from many of the confounding factors present in humans undergoing OLT and without the need to induce disease in otherwise healthy animals. Despite clinical resolution of HE and a significant reduction in portosystemic shunting, hypermanganesemia remained present in these dogs.
